The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Novel concepts in insulin regulation of hepatic gluconeogenesis
Abstract
The regulation of hepatic gluconeogenesis is an important process in the adjustment of the blood glucose level, and pathological changes in the glucose production of the liver are a central characteristic in type 2 diabetes. The pharmacological intervention in signaling events that regulate the expression of the key gluconeogenic enzymes phospho enolpyruvate carboxykinase (PEPCK) and the catalytic subunit glucose-6-phosphatase (G-6-Pase) is regarded as a potential strategy for the treatment of metabolic aberrations associated with this disease. However, such intervention requires a detailed understanding of the molecular mechanisms involved in the regulation of this process. Glucagon and glucocorticoids are known to increase hepatic gluconeogenesis by inducing the expression of PEPCK and G-6-Pase. The coactivator protein PGC-1 has been identified as an important mediator of this regulation. In contrast, insulin is known to suppress both PEPCK and G-6-Pase gene expression by the activation of PI 3-kinase. However, PI 3-kinase-independent pathways can also lead to the inhibition of gluconeogenic enzymes. This review focuses on signaling mechanisms and nuclear events that transduce the regulation of gluconeogenic enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“subsequent downregulation of gluconeogenesis (83)”
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., & Ruvkun, G. (1997) · Nature · doi:10.1038/40194 · Cited by 1,932
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148 · cited 1×
“There is evidence obtained with different methods, like NMR spectroscopy and stable isotopes, that this effect occurs mainly by reducing the rate of gluconeogenesis (30, 69), although it has also been debated that metformin may work by reducing glycogenolysis (18, 42).”
Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · cited 1×
“There is evidence obtained with different methods, like NMR spectroscopy and stable isotopes, that this effect occurs mainly by reducing the rate of gluconeogenesis (30, 69), although it has also been debated that metformin may work by reducing glycogenolysis (18, 42).”
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
Wang, X., Sato, R., Brown, M. S., Hua, X., & Goldstein, J. L. (1994) · Cell · doi:10.1016/0092-8674(94)90234-8 · Cited by 1,013
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000
Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F., & Birnbaum, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100462200 · Cited by 959
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 930
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., Ruiter, N. D. D., De Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 882
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“ism with glucose in times of starvation (13, 48, 53).”
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806 · cited 1×
“and increased glucose uptake in skeletal muscle (44).”
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Mammalian AMP-activated protein kinase subfamily
Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.611 · Cited by 652
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Insulin signaling pathways in time and space
Saltiel, A. R., & Pessin, J. E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02207-3 · Cited by 628
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
REGULATION OF GLUCOSE PRODUCTION BY THE LIVER
Nordlie, R. C., Foster, J. D., & Lange, A. J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.379 · Cited by 585
Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 521
Ets transcription factors: nuclear effectors of the Ras–MAP-kinase signaling pathway
Wasylyk, B., Hagman, J., & Gutierrez-Hartmann, A. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01211-0 · Cited by 504
Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo.
Cherrington, A. D. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1198 · Cited by 502
FOUFELLE, F., & FERRÉ, P. (2002) · Biochemical Journal · doi:10.1042/bj20020430 · Cited by 479
Cusi, K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.4059 · Cited by 455
Sasaki, K., Cripe, T. P., Koch, S. R., Andreone, T. L., Petersen, D. D., Beale, E. G., & Granner, D. K. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42541-5 · Cited by 428 · cited 1×
“The expression of the genes for G-6-Pase and PEPCK is induced by glucagon during fasting, by glucocorticoids during periods of stress, or by catecholamines during exercise (20, 26, 35, 36, 59, 62, 67).”
Glycogen synthase kinase 3: an emerging therapeutic target
Eldar-Finkelman, H. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02266-3 · Cited by 407
Lamers, W. H., Hanson, R. W., & Meisner, H. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5137 · Cited by 402
Lochhead, P. A., Salt, I. P., Walker, K. S., Hardie, D. G., & Sutherland, C. (2000) · Diabetes · doi:10.2337/diabetes.49.6.896 · Cited by 390
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
Edwards, P. A., Kast, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 385
Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin
Granner, D., Andreone, T., Sasaki, K., & Beale, E. (1983) · Nature · doi:10.1038/305549a0 · Cited by 362
O'Brien, R. M., Lucas, P. C., Forest, C. D., Magnuson, M. A., & Granner, D. K. (1990) · Science · doi:10.1126/science.2166335 · Cited by 357
Schmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., & Unterman, T. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003616200 · Cited by 349
Self-citationThe insulin signalling pathway
Lizcano, J. M., & Alessi, D. R. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00777-7 · Cited by 325
Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis
Cao, G., Liang, Y., Broderick, C. L., Oldham, B. A., Beyer, T. P., Schmidt, R. J., Zhang, Y., Stayrook, K. R., Suen, C., Otto, K. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210208200 · Cited by 299
Hall, R. K., Yamasaki, T., Kucera, T., Waltner-Law, M., O'Brien, R., & Granner, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004898200 · Cited by 284
Regulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHR
Daitoku, H., Yamagata, K., Matsuzaki, H., Hatta, M., & Fukamizu, A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.642 · Cited by 262
The Signal-Dependent Coactivator CBP Is a Nuclear Target for pp90RSK
Nakajima, T., Fukamizu, A., Takahashi, J., Gage, F. H., Fisher, T., Blenis, J., & Montminy, M. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80119-1 · Cited by 254
Jakobsen, S. N., Hardie, D. G., Morrice, N., & Tornqvist, H. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100483200 · Cited by 238
Regulation of nuclear translocation of Forkhead transcription factor AFX by protein kinase B
Takaishi, H., Konishi, H., Matsuzaki, H., Ono, Y., Shirai, Y., Saito, N., Kitamura, T., Ogawa, W., Kasuga, M., Kikkawa, U., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11836 · Cited by 238
Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2903 · Cited by 228
O'Brien, R. M., Noisin, E. L., Suwanichkul, A., Yamasaki, T., Lucas, P. C., Wang, J.-C., Powell, D. R., & Granner, D. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1747 · Cited by 226
Intracellular signalling: PDK1 – a kinase at the hub of things
Belham, C., Wu, S., & Avruch, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80058-x · Cited by 222
Lochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
FLEISCHMANN, M., & IYNEDJIAN, P. B. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490013 · Cited by 195
Insulin-regulated gene expression
O'Brien, R. M., Streeper, R. S., Ayala, J. E., Stadelmaier, B. T., & Hornbuckle, L. A. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290552 · Cited by 194
Miyake, K., Ogawa, W., Matsumoto, M., Nakamura, T., Sakaue, H., & Kasuga, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15880 · Cited by 170
Novel Roles of Liver X Receptors Exposed by Gene Expression Profiling in Liver and Adipose Tissue
Stulnig, T. M., Steffensen, K. R., Gao, H., Reimers, M., Dahlman-Wright, K., Schuster, G. U., & Gustafsson, J.-Å. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1299 · Cited by 164
Streeper, R. S., Svitek, C. A., Chapman, S. C., Greenbaum, L. E., Taub, R. A., & O’Brien, R. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11698 · Cited by 160
Sutherland, C. D., O’Brien, R. M., & Granner, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15501 · Cited by 147
Liao, J., Barthel, A., Nakatani, K., & Roth, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27320 · Cited by 141
Self-citationBécard, D., Hainault, I., Azzout‐Marniche, D., Bertry-Coussot, L., Ferré, P., & Foufelle, F. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2425 · Cited by 137
3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling
Störz, P., & Toker, A. (2002) · Frontiers in bioscience · doi:10.2741/storz · Cited by 131
Granner, D. K., Sasaki, K., & Chu, D. T. W. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb15530.x · Cited by 129
Gabbay, R. A., Sutherland, C. D., Gnudi, L., Kahn, B. B., O’Brien, R. M., Granner, D. K., & Flier, J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1890 · Cited by 129
Lange, A., Argaud, D., El‐Maghrabi, M. R., Pan, W., Maitra, S. R., & Pilkis, S. J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1702 · Cited by 123
Ayala, J. E., Streeper, R. S., Desgrosellier, J. S., Durham, S. K., Suwanichkul, A., Svitek, C. A., Goldman, J. K., Barr, F. G., Powell, D. R., & O'Brien, R. M. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1885 · Cited by 116
Dickens, M., Svitek, C. A., Culbert, A. A., O’Brien, R. M., & Tavaré, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20144 · Cited by 111
Mithieux, G., Guignot, L., Bordet, J., & Wiernsperger, N. F. (2002) · Diabetes · doi:10.2337/diabetes.51.1.139 · Cited by 108
Barthel, A., Schmoll, D., Krüger, K.-D., Bahrenberg, G., Walther, R., Roth, R. A., & Joost, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5261 · Cited by 105
Self-citationKotani, K., Ogawa, W., Hino, Y., Kitamura, T., Ueno, H., Sano, W., Sutherland, C. D., Granner, D. K., & Kasuga, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21305 · Cited by 99
Chakravarty, K., Leahy, P. S., Bécard, D., Hakimi, P., Foretz, M., Ferré, P., Foufelle, F., & Hanson, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103310200 · Cited by 98
Schmoll, D., Wasner, C., HINDS, C. J., Allan, B. B., Walther, R., & Burchell, A. N. (1999) · Biochemical Journal · doi:10.1042/bj3380457 · Cited by 96
Self-citationArizmendi, C., Liu, S., Croniger, C. M., Poli, V., & Friedman, J. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13033 · Cited by 90
Insulin Suppresses Transactivation by CAAT/Enhancer-binding Proteins β (C/EBPβ)
Guo, S., Cichy, S. B., He, X., Yang, Q., Ragland, M., Ghosh, A. K., Johnson, P. F., & Unterman, T. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008542200 · Cited by 89
Agati, J. M., Yeagley, D., & Quinn, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18751 · Cited by 89
Barthel, A., Schmoll, D., Krüger, K.-D., Roth, R. A., & Joost, H. (2002) · Endocrinology · doi:10.1210/endo.143.8.8792 · Cited by 76
Self-citationThe Molecular Physiology of Hepatic Nuclear Factor 3 in the Regulation of Gluconeogenesis
Wang, J.-C., Stafford, J. M., Scott, D. K., Sutherland, C. D., & Granner, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14717 · Cited by 61
Sutherland, C. D., Waltner-Law, M. E., Gnudi, L., Kahn, B. B., & Granner, D. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3198 · Cited by 59
Waltner-Law, M. E., Daniels, M. C., Sutherland, C. D., & Granner, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003656200 · Cited by 44
An mRNA Splice Variant of the AFX Gene with Altered Transcriptional Activity
Yang, Z., Whelan, J., Babb, R., & Bowen, B. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106091200 · Cited by 24
Schmoll, D., Grempler, R., Barthel, A., Joost, H., & Walther, R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570867 · Cited by 22
Self-citation
Cited by
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
“It is tempting to speculate that chemical compounds that selectively disrupt the docking of PGC-1α on these gluconeogenic transcription factors may provide a novel therapeutic modality for the treatment of hyperglycemia (Barthel and Schmoll, 2003).”
BackgroundKino, T., Hurt, D. E., Ichijo, T., Nader, N., & Chrousos, G. P. (2010) · Science Signaling · doi:10.1126/scisignal.2000568 · Cited by 1,231
Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
“Pharmacological inhibition of this pathway has been proposed as a method to restore insulin sensitivity, which has been validated by the antidiabetic drug metformin, that reduces hepatic glucose production via inhibition of gluconeogenesis (Barthel and Schmoll, 2003).”
MethodActivation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Regulation of Fasted Blood Glucose by Resistin
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., et al. (2004) · Science · doi:10.1126/science.1092341 · Cited by 725
Metadata
- Authors
- Barthel, A., & Schmoll, D.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2003-10
- Volume
- 285
- Issue
- 4
- Pages
- E685-E692
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2145333208
- Cited by
- 515
- References
- 85
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.